From: 	Carolyn Nielsen
To:	Eleanor Riley; Matthew White; Martin Goodier
Date: 	09/03/2015 08:56
Subject: 	Transférer : 14-03080-FLR1 Decision Letter

Good news :)
 
Did you receive this email? If not, I will forward to Christian, Ana, and Scarlett too.
 
Matt- I am hoping they don't need me to do anything else with the figures but if they do I may need to have some help as my Prism trial will expire in the next few days. My laptop keeps restarting so haven't been able to just leave it open indefinitely like Reuben did!
 
Carolyn

>>> <infoji@aai.org> 06/03/15 21:27 >>>
 IMPORTANT: If you will not be available to return page proofs during the period below, an alternate contact must be supplied to aai_specialists.djs@sheridan.com 

Dear Ms. Nielsen: 

Congratulations! I am pleased to inform you that your manuscript titled "Impaired Natural Killer Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals" has been accepted for publication in The Journal of Immunology, contingent upon a satisfactory outcome when figures are screened for evidence of manipulation (for more information see http://jimmunol.org/site/misc/authorinstructions.xhtml#digitalimages). The Journal of Immunology staff will contact you if there are any questions concerning the figures. 

If there are no questions about the figures, you will receive an e-mail from Dartmouth Journal Services two to four weeks after receipt of this e-mail. The Dartmouth Journal Services email will give you access to your page proofs in PDF format. After you receive access to your page proofs, please return them to Dartmouth Journal Services WITHIN 24 HOURS to avoid delay in publication. 

If you will not be available during the next 14- to 32-days, an alternate contact must be supplied. Please contact The JI Production Team at aai_specialists.djs@sheridan.com with an alternate e-mail address or contact information for another author on your manuscript. We cannot reschedule or delay the delivery date of the manuscript proofs. 

To receive an email when your article publishes ahead of print (Next in The JI feature), sign up at http://www.jimmunol.org/cgi/alerts/ctmain by creating an author alert. 

Thank you for submitting your manuscript to The Journal of Immunology. 

Sincerely, 

Pamela J. Fink, Ph.D. 
Editor-in-Chief, The Journal of Immunology